Mouse gastric tumor models with prostaglandin E2 pathway activation show similar gene expression profiles to intestinal-type human gastric cancer

BMC Genomics

Volumn 10, Issue , 2009, Pages

  Itadani, Hiraku ^a   Oshima, Hiroko ^b   Oshima, Masanobu ^b   Kotani, Hidehito ^a  

^a BANYU PHARMACEUTICAL CO LTD   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTAGLANDIN E2; WNT PROTEIN; DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER CLASSIFICATION; CANCER TISSUE; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; LUNG CANCER; MAJOR CLINICAL STUDY; MICROARRAY ANALYSIS; MOLECULAR MECHANICS; MOUSE; NONHUMAN; STOMACH CANCER; STOMACH CARCINOGENESIS; TRANSGENIC MOUSE; ANIMAL; COMPARATIVE GENOMIC HYBRIDIZATION; DISEASE MODEL; DNA MICROARRAY; DNA SEQUENCE; EXPERIMENTAL NEOPLASM; GENETICS; METABOLISM; STOMACH TUMOR;

MUS; MUS MUSCULUS;

ANIMALS; COMPARATIVE GENOMIC HYBRIDIZATION; DINOPROSTONE; DISEASE MODELS, ANIMAL; DNA, NEOPLASM; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MICE; MICE, TRANSGENIC; NEOPLASMS, EXPERIMENTAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEQUENCE ANALYSIS, DNA; STOMACH NEOPLASMS; WNT PROTEINS;

EID: 74549158796     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-615     Document Type: Article

References (42)

1. Lauren P. The two histological main types of gastric carcinoma - diffuse and so-called intestinal-type carcinoma - An attempt at a histo-clinical classification. Acta Pathologica et Microbiologica Scandinavica 1965, 64:31-49.
2. Tahara E. Genetic pathways of two types of gastric cancer. Iarc Sci Publ 2004, 327-349.
3. Vauhkonen M, Vauhkonen H, Sipponen P. Pathology and molecular biology of gastric cancer. Best Practice & Research in Clinical Gastroenterology 2006, 20:651-674.
4. Yokota J, Yamamoto T, Miyajima N, Toyoshima K, Nomura N, Sakamoto H, Yoshida T, Terada M, Sugimura T. Genetic alterations of the c-erbB-2 oncogene occur frequently in tubular adenocarcinoma of the stomach and are often accompanied by amplification of the v-erbA homologue. Oncogene 1988, 2:283-287.
5. Kameda T, Yasui W, Yoshida K, Tsujino T, Nakayama H, Ito M, Ito H, Tahara E. Expression of ERBB2 in Human Gastric Carcinomas: Relationship between p185ERBB2 Expression and the Gene Amplification. Cancer Research 1990, 50:8002-8009.
6. Tsugawa K, Yonemura Y, Hirono Y, Fushida S, Kaji M, Miwa K, Miyazaki I, Yamamoto H. Amplification of the c-met, c-erbB2 and epidermal growth factor receptor gene in human gastric cancers: Correlation to clinical features. Oncology 1998, 55:475-481. 10.1159/000011898, 9732228.
7. Yonemura Y, Ninomiya I, Ohoyama S, Kimura H, Yamaguchi A, Fushida S, Kosaka T, Miwa K, Miyazaki I, Endou Y, Tanaka M, Sasaki T. Expression of c-erbB-2 Oncoprotein in Gastric Carcinoma. Immunoreactivity for c-erbB-2 Protein is an Independent Indicator of Poor Short-Term Prognosis in Patients With Gastric Carcinoma. Cancer 1991, 67:2914-2918. 10.1002/1097-0142(19910601)67:11<2914::AID-CNCR2820671134>.0.CO;2-G, 1673870.
8. Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W, Funke I. E-Cadherin Expression in Primary and Metastatic Gastric Cancer: Down-Regulation Correlates with Cellular Dedifferentiation and Glandular Disintegration. Cancer Research 1993, 53:1690-1695.
9. Gabbert HE, Mueller W, Schneiders A, Meier S, Moll R, Birchmeier W, Hommel G. Prognostic value of E-cadherin expression in 413 gastric carcinomas. International Journal of Cancer 1996, 69:184-189.
10. Ascano JJ, Frierson H, Moskaluk CA, Harper JC, Roviello F, Jackson CE, El Rifai W, Vindigni C, Tosi P, Powell SM. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Modern Pathology 2001, 14:942-949. 10.1038/modpathol.3880416, 11598162.
11. Guilford P, Hopkins J, Harraway J, McLeod M, McLeod N, Harawira P, Taite H, Scoular R, Miller A, Reeve AE. E-cadherin germline mutations in familial gastric cancer. Nature 1998, 392:402-405. 10.1038/32918, 9537325.
12. Berx G, Becker KF, Hofler H, van Roy F. Mutations of the human E-cadherin (CDH1) gene. Human Mutation 1998, 12:226-237. 10.1002/(SICI)1098-1004(1998)12:4<226::AID-HUMU2>.0.CO;2-D, 9744472.
13. Ebert MPA, Fei G, Kahmann S, Muller O, Yu J, Sung JJY, Malfertheiner P. Increased β-catenin mRNA levels and mutational alterations of the APC and β-catenin gene are present in intestinal-type gastric cancer. Carcinogenesis 2002, 23:87-91. 10.1093/carcin/23.1.87, 11756228.
14. Saukkonen K, Nieminen O, van Rees B, Vilkki S, Harkonen M, Juhola M, Mecklin JP, Sipponen P, Ristimaki A. Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma. Clinical Cancer Research 2001, 7:1923-1931.
15. Boussioutas A, Li H, Liu J, Waring P, Lade S, Holloway AJ, Taupin D, Gorringe K, Haviv I, Desmond PV, Bowtell DDL. Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer. Cancer Research 2003, 63:2569-2577.
16. Jinawath N, Furukawa Y, Hasegawa S, Li MH, Tsunoda T, Satoh S, Yamaguchi T, Imamura H, Inoue M, Shiozaki H, Nakamura Y. Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 2004, 23:6830-6844. 10.1038/sj.onc.1207886, 15273739.
17. Oshima H, Oshima M, Inaba K, Taketo MM. Hyperplastic gastric tumors induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO Journal 2004, 23:1669-1678. 10.1038/sj.emboj.7600170, 391075, 15014433.
18. Oshima H, Matsunaga A, Fujimura T, Tsukamoto T, Taketo MM, Oshima M. Carcinogenesis in mouse stomach by simultaneous activation of the Wnt signaling and prostaglandin E2 pathway. Gastroenterology 2006, 131:1086-1095. 10.1053/j.gastro.2006.07.014, 17030179.
19. Oshima H, Itadani H, Kotani H, Taketo MM, Oshima M. Induction of prostaglandin E2 pathway promotes gastric hamartoma development with suppression of bone morphogenetic protein signaling. Cancer Research 2009, 69:2729-2733. 10.1158/0008-5472.CAN-08-4394, 19318548.
20. Chen X, Leung SY, Yuen ST, Chu KM, Ji JF, Li R, Chan ASY, Law S, Troyanskaya OG, Wong J, So S, Botstein D, Brown PO. Variation in gene expression patterns in human gastric cancers. Molecular Biology of the Cell 2003, 14:3208-3215. 10.1091/mbc.E02-12-0833, 181561, 12925757.
21. Sano T, Tsujino T, Yoshida K, Nakayama H, Haruma K, Ito H, Nakamura Y, Kajiyama G, Tahara E. Frequent Loss of Heterozygosity on Chromosomes 1q, 5q, and 17p in Human Gastric Carcinomas. Cancer Research 1991, 51:2926-2931.
22. Uchino S, Tsuda H, Noguchi M, Yokota J, Terada M, Saito T, Kobayashi M, Sugimura T, Hirohashi S. Frequent Loss of Heterozygosity at the DCC Locus in Gastric Cancer. Cancer Research 1992, 52:3099-3102.
23. Park WS, Oh RR, Park JY, Lee SH, Shin MS, Kim YS, Kim SY, Lee HK, Kim PJ, Oh ST, Yoo NJ, Lee JY. Frequent Somatic Mutations of the β-catenin Gene in Intestinal-Type Gastric Cancer. Cancer Research 1999, 59:4257-4260.
24. Nakatsuru S, Yanagisawa A, Ichii S, Tahara E, Kato Y, Nakamura Y, Horii A. Somatic mutation of the APC gene in gastric cancer: Frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Human Molecular Genetics 1992, 1:559-563. 10.1093/hmg/1.8.559, 1338691.
25. Parsonnet J, Vandersteen D, Goates J, Sibley RK, Pritikin J, Chang Y. Helicobacter pylori Infection in Intestinal-Type and Diffuse-Type Gastric Adenocarcinomas. Journal of the National Cancer Institute 1991, 83:640-643. 10.1093/jnci/83.9.640, 2023282.
26. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, Taniyama K, Sasaki N, Schlemper RJ. Helicobacter pylori Infection and the Development of Gastric Cancer. New England Journal of Medicine 2001, 345:784-789. 10.1056/NEJMoa001999, 11556297.
27. Akhtar M, Cheng YL, Magno RM, Ashktorab H, Smoot DT, Meltzer SJ, Wilson KT. Promoter Methylation Regulates Helicobacter pylori-stimulated Cyclooxygenase-2 Expression in Gastric Epithelial Cells. Cancer Research 2001, 61:2399-2403.
28. Yamagata R, Shimoyama T, Fukuda S, Yoshimura T, Tanaka M, Munakata A. Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia. European Journal of Gastroenterology & Hepatology 2002, 14:359-363.
29. Wright PA, Williams GT. Molecular biology and gastric carcinoma. Gut 1993, 34:145-147. 10.1136/gut.34.2.145, 1373957, 8432461.
30. Tahara E. Genetic Alterations in Human Gastrointestinal Cancers - the Application to Molecular Diagnosis. Cancer 1995, 75:1410-1417. 10.1002/1097-0142(19950315)75:6+<1410::AID-CNCR2820751504>.0.CO;2-O, 7889467.
31. Lee JS, Grisham JW, Thorgeirsson SS. Comparative functional genomics for identifying models of human cancer. Carcinogenesis 2005, 26:1013-1020. 10.1093/carcin/bgi030, 15677630.
32. Herschkowitz JI, Simin K, Weigman VJ, Mikaelian I, Usary J, Hu ZY, Rasmussen KE, Jones LP, Assefnia S, Chandrasekharan S, Backlund MG, Yin YZ, Khramtsov AI, Bastein R, Quackenbush J, Glazer RI, Brown PH, Green JE, Kopelovich L, Furth PA, Palazzo JP, Olopade OI, Bernard PS, Churchill GA, Van Dyke T, Perou CM. Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors. Genome Biology 2007, 8:R76. 10.1186/gb-2007-8-5-r76, 1929138, 17493263.
33. He XC, Zhang JW, Tong WG, Tawfik O, Ross J, Scoville DH, Tian Q, Zeng X, He X, Wiedemann LM, Mishina Y, Li LH. BMP signaling inhibits intestinal stem cell self-renewal through suppression of Wnt-β-catenin signaling. Nature Genetics 2004, 36:1117-1121. 10.1038/ng1430, 15378062.
34. Zhao Y, Geverd DA. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-β signaling. Biochemical and Biophysical Research Communications 2002, 294:319-23. 10.1016/S0006-291X(02)00471-0, 12051713.
35. Gene Expression Omnibus. , http://www.ncbi.nlm.nih.gov/geo/
36. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, Rijn M, Jeffrey SS, Thorsen T, Quist H, Matese JC, Brown PO, Botstein D, Lonning PE, Borresen-Dale AL. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America 2001, 98:10869-10874. 10.1073/pnas.191367098, 58566, 11553815.
37. Stanfrod Microarray Database. , http://genome-www5.stanford.edu/
38. Kaiser S, Park YK, Franklin JL, Halberg RB, Yu M, Jessen WJ, Freudenberg J, Chen XD, Haigis K, Jegga AG, Kong S, Sakthivel B, Xu H, Reichling T, Azhar M, Boivin GP, Roberts RB, Bissahoyo AC, Gonzales F, Bloom GC, Eschrich S, Carter SL, Aronow JE, Kleimeyer J, Kleimeyer M, Ramaswamy V, Settle SH, Boone B, Levy S, Graff JM, Doetschman T, Groden J, Dove WF, Threadgill DW, Yeatman TJ, Coffey RJ, Aronow BJ. Transcriptional recapitulation and subversion of embryonic colon development by mouse colon tumor models and human colon cancer. Genome Biology 2007, 8:R131. 10.1186/gb-2007-8-7-r131, 2323222, 17615082.
39. Beer DG, Kardia SLR, Huang CC, Giordano TJ, Levin AM, Misek DE, Lin L, Chen GA, Gharib TG, Thomas DG, Lizyness ML, Kuick R, Hayasaka S, Taylor JMG, Iannettoni MD, Orringer MB, Hanash S. Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nature Medicine 2002, 8:816-824.
40. The United States National Cancer Institute website. , https://array.nci.nih.gov/caarray/project/beer-00153
41. Benjamini Y, Hochberg Y. Controlling the false discovery rate: A practical and powerful approach to multiple testing. Journal of the Royal Statistical Society 1995, 57:289-300.
42. Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, Kasarskis A, Zhang B, Wang S, Suver C, Zhu J, Millstein J, Sieberts S, Lamb J, GuhaThakurta D, Derry J, Storey JD, Avila-Campillo I, Kruger MJ, Johnson JM, Rohl CA, van Nas A, Mehrabian M, Drake TA, Lusis AJ, Smith RC, Guengerich FP, Strom SC, Schuetz E, Rushmore TH, Ulrich R. Mapping the genetic architecture of gene expression in human liver. PLoS Biology 2008, 6:e107. 10.1371/journal.pbio.0060107, 2365981,2365981, 18462017.